<DOC>
	<DOCNO>NCT00190216</DOCNO>
	<brief_summary>The hypothesis study transcranial magnetic stimulation ( TMS ) focus hyperfunctional cerebral area effective treat depressive symptom stimulation take account functional specificity patient . The goal compare effect `` guide '' TMS , use neuroimaging guide TMS dysfunctional cortical region individually detect neuroimaging , `` standard TMS '' , use study , leave prefrontal cortex , sham TMS , patient resistant depression .</brief_summary>
	<brief_title>Assessing Repetitive Transcranial Magnetic Stimulation Treatment Refractory Depression ( rTMS )</brief_title>
	<detailed_description>The objective study : - To localize site low frontal activity patient resistant depression , use PET measure regional cerebral metabolic rate glucose ( rCMRGlu ) . - To demonstrate high-frequency TMS ( 10Hz ) guide site effective standard sham TMS , resistant depress patient , use double blind controlled procedure . - To assess effect TMS regional cerebral metabolism use rCMRGlu PET 10 session TMS treatment . Depressed patient meet DSM-IV criterion Major Depressive Disorder , age 18 55 , include . They meet criterion depression resistant antidepressant drug They randomise 3 group : guide prefrontal TMS , standard leave prefrontal sham leave prefrontal TMS . rTMS administer daily working day , two week . Ten stimuli per second ( 10Hz ) apply 20 course patient receive 1600 stimulus per day . Guided TMS prefrontal target correspond high statistically significant hyperfunctional cluster determine rCMRGlu PET . Standard stimulation leave pre-frontal , 5 cm anterior optimal stimulation point abductor pollex brevis . Stimulation strength choose 90 % relative motor threshold . Sham rTMS use procedure identical real standard treatment , use sham coil .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Treatment-Resistant</mesh_term>
	<criteria>Major depression ( accord DSMIV ) resistant least two medical antidepressant treatment different pharmacological action , prescribe least one month effective dosage , without therapeutical result . Hospitalisation service investigator Informed consent sign Presence metallic part inside body ( pacemaker , vascular clip , cardiac valve , prothesis ... ) Severe somatic central nervous system disease Familial history comitiality Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Resistant depression</keyword>
	<keyword>Transcranial Magnetic Stimulation ,</keyword>
	<keyword>Neuroimaging</keyword>
</DOC>